American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

ClearPoint Neuro, Inc. (CLPT)

$9.14 -1.19% NASDAQ: CLPT · 15-min delayed

SOLANA BEACH, California
Public · NASDAQ: CLPT
172 employees

Visit website Follow

$423.5MMarket cap

$37.0MRevenue · FY2025

-$25.5MNet income

172Employees

CLPTNASDAQ

2012IPO

About ClearPoint Neuro, Inc.

ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Company facts

Type: Public · NASDAQ: CLPT
Employees: 172
IPO date: May 18, 2012
Headquarters: 120 S. SIERRA AVENUE
SOLANA BEACH, California 92075
Phone: (949) 900-6833
Industry: Medical Devices
Website: Visit site

Registry IDs

Ticker: CLPT Nasdaq
SEC CIK: 1285550
LEI: 549300I1AHR8KMMFIS52
EIN: 582394628
SIC: 3841 SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

Explore our data studies: the biggest company in every US state · all rankings & reports.

Embed this company’s badge

Show ClearPoint Neuro, Inc.’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/clearpoint-neuro-inc/"><img src="https://americancompanies.com/badge/clearpoint-neuro-inc.svg" alt="ClearPoint Neuro, Inc. — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it free, control the page, and activate the embeddable Verified badge for their own website.

Claim this profile — free

Track American companies

Create a free account to follow ClearPoint Neuro, Inc. and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Revenue FY2025: $37.0M
Net income: -$25.5M
Total assets: $97.7M
Market cap: $423.5M

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: CLPT

$9.14 -1.19%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$8.66 $29.60

52-week range

Market cap: $423.5M
Shares outstanding: 46.3M
Open: —
Day range: –
Prev close: —
Volume: —
IPO date: May 18, 2012

ClearPoint Neuro, Inc. (CLPT) Stock Price

Reported a net loss of $25.5M in FY2025.
Trading 69% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review ClearPoint Neuro, Inc..

Write a review

Newsroom

News about ClearPoint Neuro, Inc.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ClearPoint Neuro, Inc. - CLPT GlobeNewswire Inc. · 2026-10-13 · negative AngioDynamics (ANGO) Reports Q1 Loss, Lags Revenue Estimates Zacks Investment Research · 2026-10-08 · neutral Global MRI Guided Neurosurgical Ablation Market Poised for Steady Growth, Projected to Reach USD 227.56 Million by 2034 Driven by Growing Adoption and Advancements in Non-Cooled Laser Systems: FMI GlobeNewswire Inc. · 2024-11-20 · neutral ClearPoint Neuro Congratulates Partner Aspen Neuroscience on Use of the ClearPoint® Navigation System for All Enrolled Patients in ASPIRO Clinical Trial GlobeNewswire Inc. · 2024-06-20 ClearPoint's (CLPT) New Products to Boost Neurosurgical Segment Zacks Investment Research · 2024-06-03 ClearPoint Neuro Announces Full Market Release of SmartFrame OR™ and ClearPoint PRISM® 3T Laser Therapy System GlobeNewswire Inc. · 2024-06-01

News & sentiment via Polygon.io

FAQ

ClearPoint Neuro, Inc.: frequently asked questions

Is ClearPoint Neuro, Inc. an American company?

ClearPoint Neuro, Inc. is a US-based company headquartered in Solana Beach, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is ClearPoint Neuro, Inc. headquartered?

ClearPoint Neuro, Inc. is headquartered in Solana Beach, California, United States.

Is ClearPoint Neuro, Inc. publicly traded?

Yes — ClearPoint Neuro, Inc. is a publicly traded company. Its stock trades under the ticker symbol CLPT on the NASDAQ.

What does ClearPoint Neuro, Inc. do?

ClearPoint Neuro, Inc. is an American Medical Devices company in the Health & Beauty sector.

Explore